Home > Insider Trading > Filing (0001385508-18-000117)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1385508	Opiant Pharmaceuticals Inc.	OPNT	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1358116	Phil Skolnick	C/O Opiant Pharmaceuticals, Inc. 201 Santa Monica Blvd., Suite 500 Santa Monica CA 90401	Chief Scientific Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2018-12-03	4,321	$9.00	4,321	No	4	M	Direct
Common Stock	Disposition	2018-12-03	1,306	$15.85	3,015	No	4	S	Direct
Common Stock	Disposition	2018-12-06	3,015	$16.15	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2018-12-03	10,000	$0.00	4,321	$9.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
170,000	2018-08-06	2027-02-06	No	4	M	Direct

Footnotes

The option was exercised pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person.
The shares were sold pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person.
Pursuant to the Stock Option Agreement, the number of shares issued on a cashless basis is determined by the following formula: Number of shares = (number of options times (prior day stock price less exercise price)) divided by the prior day stock price.